<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36830790</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">254</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11020254</ELocationID><Abstract><AbstractText>GABA and GABA<sub>A</sub>-receptors (GABA<sub>A</sub>-Rs) play major roles in neurodevelopment and neurotransmission in the central nervous system (CNS). There has been a growing appreciation that GABA<sub>A</sub>-Rs are also present on most immune cells. Studies in the fields of autoimmune disease, cancer, parasitology, and virology have observed that GABA-R ligands have anti-inflammatory actions on T cells and antigen-presenting cells (APCs), while also enhancing regulatory T cell (Treg) responses and shifting APCs toward anti-inflammatory phenotypes. These actions have enabled GABA<sub>A</sub>-R ligands to ameliorate autoimmune diseases, such as type 1 diabetes (T1D), multiple sclerosis (MS), and rheumatoid arthritis, as well as type 2 diabetes (T2D)-associated inflammation in preclinical models. Conversely, antagonism of GABA<sub>A</sub>-R activity promotes the pro-inflammatory responses of T cells and APCs, enhancing anti-tumor responses and reducing tumor burden in models of solid tumors. Lung epithelial cells also express GABA-Rs, whose activation helps maintain fluid homeostasis and promote recovery from injury. The ability of GABA<sub>A</sub>-R agonists to limit both excessive immune responses and lung epithelial cell injury may underlie recent findings that GABA<sub>A</sub>-R agonists reduce the severity of disease in mice infected with highly lethal coronaviruses (SARS-CoV-2 and MHV-1). These observations suggest that GABA<sub>A</sub>-R agonists may provide off-the-shelf therapies for COVID-19 caused by new SARS-CoV-2 variants, as well as novel beta-coronaviruses, which evade vaccine-induced immune responses and antiviral medications. We review these findings and further advance the notions that (1) immune cells possess GABA<sub>A</sub>-Rs to limit inflammation in the CNS, and (2) this natural "braking system" on inflammatory responses may be pharmacologically engaged to slow the progression of autoimmune diseases, reduce the severity of COVID-19, and perhaps limit neuroinflammation associated with long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jide</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular and Medical Pharmacology, UCLA School of Medicine, University of California, Los Angeles, CA 90095-1735, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Molecular and Medical Pharmacology, UCLA School of Medicine, University of California, Los Angeles, CA 90095-1735, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">GABA</Keyword><Keyword MajorTopicYN="N">GABAA-receptor</Keyword><Keyword MajorTopicYN="N">GABAB-receptor</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">homotaurine</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList><CoiStatement>D.L.K. and J.T. are inventors of GABA-related patents. D.L.K. is an inventor of GAD-related patents and serves on the Scientific Advisory Board of Diamyd Medical. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36830790</ArticleId><ArticleId IdType="pmc">PMC9953446</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11020254</ArticleId><ArticleId IdType="pii">biomedicines11020254</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron. 1991;7:91&#x2013;100. doi: 10.1016/0896-6273(91)90077-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(91)90077-D</ArticleId><ArticleId IdType="pubmed">2069816</ArticleId></ArticleIdList></Reference><Reference><Citation>Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: Why? Trends Pharmacol. Sci. 1998;19:500&#x2013;505. doi: 10.1016/S0165-6147(98)01270-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(98)01270-X</ArticleId><ArticleId IdType="pubmed">9871412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 1991;56:720&#x2013;723. doi: 10.1111/j.1471-4159.1991.tb08211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1991.tb08211.x</ArticleId><ArticleId IdType="pmc">PMC8194030</ArticleId><ArticleId IdType="pubmed">1988566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.E., Lee Y., Lee G.H. The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain. Arch. Pharm. Res. 2019;42:1031&#x2013;1039. doi: 10.1007/s12272-019-01196-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-019-01196-z</ArticleId><ArticleId IdType="pubmed">31786745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaani J., Kolibachuk J., Martinez H., Baekkeskov S. Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters. J. Cell Biol. 2010;190:911&#x2013;925. doi: 10.1083/jcb.200912101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200912101</ArticleId><ArticleId IdType="pmc">PMC2935578</ArticleId><ArticleId IdType="pubmed">20805323</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen R.W., Sieghart W. GABA A receptors: Subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56:141&#x2013;148. doi: 10.1016/j.neuropharm.2008.07.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2008.07.045</ArticleId><ArticleId IdType="pmc">PMC3525320</ArticleId><ArticleId IdType="pubmed">18760291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Ari Y. Excitatory actions of gaba during development: The nature of the nurture. Nat. Rev. Neurosci. 2002;3:728&#x2013;739. doi: 10.1038/nrn920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn920</ArticleId><ArticleId IdType="pubmed">12209121</ArticleId></ArticleIdList></Reference><Reference><Citation>Deidda G., Bozarth I.F., Cancedda L. Modulation of GABAergic transmission in development and neurodevelopmental disorders: Investigating physiology and pathology to gain therapeutic perspectives. Front. Cell. Neurosci. 2014;8:119. doi: 10.3389/fncel.2014.00119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00119</ArticleId><ArticleId IdType="pmc">PMC4033255</ArticleId><ArticleId IdType="pubmed">24904277</ArticleId></ArticleIdList></Reference><Reference><Citation>Couve A., Moss S.J., Pangalos M.N. GABAB receptors: A new paradigm in G protein signaling. Mol. Cell. Neurosci. 2000;16:296&#x2013;312. doi: 10.1006/mcne.2000.0908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.2000.0908</ArticleId><ArticleId IdType="pubmed">11085869</ArticleId></ArticleIdList></Reference><Reference><Citation>Evenseth L.S.M., Gabrielsen M., Sylte I. The GABAB Receptor-Structure, Ligand Binding and Drug Development. Molecules. 2020;25:3093. doi: 10.3390/molecules25133093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25133093</ArticleId><ArticleId IdType="pmc">PMC7411975</ArticleId><ArticleId IdType="pubmed">32646032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriyama K., Sze P.Y. Blood-brain barrier to H3-gamma-aminobutyric acid in normal and amino oxyacetic acid-treated animals. Neuropharmacology. 1971;10:103&#x2013;108. doi: 10.1016/0028-3908(71)90013-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0028-3908(71)90013-X</ArticleId><ArticleId IdType="pubmed">5569303</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldendorf W.H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 1971;221:1629&#x2013;1639. doi: 10.1152/ajplegacy.1971.221.6.1629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplegacy.1971.221.6.1629</ArticleId><ArticleId IdType="pubmed">5124307</ArticleId></ArticleIdList></Reference><Reference><Citation>Loscher W., Frey H.H. Transport of GABA at the blood-CSF interface. J. Neurochem. 1982;38:1072&#x2013;1079. doi: 10.1111/j.1471-4159.1982.tb05350.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1982.tb05350.x</ArticleId><ArticleId IdType="pubmed">6801203</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraf H. Transport of 14C-gamma-aminobutyric acid into brain, cerebrospinal fluid and choroid plexus in neonatal and adult rats. Brain Res. Dev. Brain Res. 2002;139:121&#x2013;129. doi: 10.1016/S0165-3806(02)00537-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-3806(02)00537-0</ArticleId><ArticleId IdType="pubmed">12480126</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Chau C., Hales T.G., Kaufman D.L. GABA(A) receptors mediate inhibition of T cell responses. J. Neuroimmunol. 1999;96:21&#x2013;28. doi: 10.1016/S0165-5728(98)00264-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(98)00264-1</ArticleId><ArticleId IdType="pubmed">10227421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Lu Y., Zhang H., Chau C.H., Dang H.N., Kaufman D.L. Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J. Immunol. 2004;173:5298&#x2013;5304. doi: 10.4049/jimmunol.173.8.5298.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.8.5298</ArticleId><ArticleId IdType="pubmed">15470076</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam S., Laughton D.L., Walding A., Wolstenholme A.J. Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol. Immunol. 2006;43:1432&#x2013;1442. doi: 10.1016/j.molimm.2005.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2005.07.025</ArticleId><ArticleId IdType="pubmed">16213022</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Glinka Y., Hasilo C., Paraskevas S., Li X., Wang Q. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone. Transplantation. 2013;96:616&#x2013;623. doi: 10.1097/TP.0b013e31829c24be.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0b013e31829c24be</ArticleId><ArticleId IdType="pubmed">23851932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Vogelzang A., Miyajima M., Sugiura Y., Wu Y., Chamoto K., Nakano R., Hatae R., Menzies R.J., Sonomura K., et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature. 2021;599:471&#x2013;476. doi: 10.1038/s41586-021-04082-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04082-1</ArticleId><ArticleId IdType="pmc">PMC8599023</ArticleId><ArticleId IdType="pubmed">34732892</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani N., Qiu H., Aleksic M., Glinka Y., Zhao F., Liu R., Li Y., Zhang N., Chakrabarti R., Ng T., et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc. Natl. Acad. Sci. USA. 2011;108:11692&#x2013;11697. doi: 10.1073/pnas.1102715108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102715108</ArticleId><ArticleId IdType="pmc">PMC3136292</ArticleId><ArticleId IdType="pubmed">21709230</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Yong J., Dang H., Kaufman D.L. Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis. Autoimmunity. 2011;44:465&#x2013;470. doi: 10.3109/08916934.2011.571223.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2011.571223</ArticleId><ArticleId IdType="pmc">PMC5787624</ArticleId><ArticleId IdType="pubmed">21604972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Dang H.N., Yong J., Chui W.S., Dizon M.P., Yaw C.K., Kaufman D.L. Oral treatment with gamma-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS ONE. 2011;6:e25338. doi: 10.1371/journal.pone.0025338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025338</ArticleId><ArticleId IdType="pmc">PMC3178643</ArticleId><ArticleId IdType="pubmed">21966503</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Dang H., O&#x2019;Laco K., Song M., Tiu B.-C., S G., Zakarian C., Kaufman D. Homotaurine treatment enhances CD4+ and CD8+ Treg responses and synergizes with low-dose anti-CD3 to enhance diabetes remission in type 1 diabetic mice. ImmuoHorizons. 2019;3:498&#x2013;510. doi: 10.4049/immunohorizons.1900019.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.1900019</ArticleId><ArticleId IdType="pmc">PMC6823932</ArticleId><ArticleId IdType="pubmed">31636084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Dang H., Wallner M., Olsen R., Kaufman D.L. Homotaurine, a safe blood-brain barrier permeable GABAA-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis. Sci. Rep. 2018;8:16555. doi: 10.1038/s41598-018-32733-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32733-3</ArticleId><ArticleId IdType="pmc">PMC6224391</ArticleId><ArticleId IdType="pubmed">30410049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Song M., Kaufman D.L. Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis. Sci. Rep. 2021;11:5402. doi: 10.1038/s41598-021-84751-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84751-3</ArticleId><ArticleId IdType="pmc">PMC7940650</ArticleId><ArticleId IdType="pubmed">33686135</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M., Tian J., Middleton B., Nguyen C.Q., Kaufman D.L. GABA Administration Ameliorates Sjogren&#x2019;s Syndrome in Two Different Mouse Models. Biomedicines. 2022;10:129. doi: 10.3390/biomedicines10010129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10010129</ArticleId><ArticleId IdType="pmc">PMC8773584</ArticleId><ArticleId IdType="pubmed">35052808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat R., Axtell R., Mitra A., Miranda M., Lock C., Tsien R.W., Steinman L. Inhibitory role for GABA in autoimmune inflammation. Proc. Natl. Acad. Sci. USA. 2010;107:2580&#x2013;2585. doi: 10.1073/pnas.0915139107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0915139107</ArticleId><ArticleId IdType="pmc">PMC2823917</ArticleId><ArticleId IdType="pubmed">20133656</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Dang H., Nguyen A.V., Chen Z., Kaufman D.L. Combined therapy with GABA and proinsulin/alum acts synergistically to restore long-term normoglycemia by modulating T-cell autoimmunity and promoting beta-cell replication in newly diabetic NOD mice. Diabetes. 2014;63:3128&#x2013;3134. doi: 10.2337/db13-1385.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1385</ArticleId><ArticleId IdType="pmc">PMC4141368</ArticleId><ArticleId IdType="pubmed">25146474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendu S.K., Akesson L., Jin Z., Edlund A., Cilio C., Lernmark A., Birnir B. Increased GABAA channel subunits expression in CD8+ but not in CD4+ T cells in BB rats developing diabetes compared to their congenic littermates. Mol. Immunol. 2011;48:399&#x2013;407. doi: 10.1016/j.molimm.2010.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2010.08.005</ArticleId><ArticleId IdType="pubmed">21112637</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanger C.M., Neben A.L., Cahalan M.D. Differential Ca2+ influx, KCa channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes. J. Immunol. 2000;164:1153&#x2013;1160. doi: 10.4049/jimmunol.164.3.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.3.1153</ArticleId><ArticleId IdType="pubmed">10640725</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber K.S., Miller M.J., Allen P.M. Th17 cells exhibit a distinct calcium profile from Th1 and Th2 cells and have Th1-like motility and NF-AT nuclear localization. J. Immunol. 2008;180:1442&#x2013;1450. doi: 10.4049/jimmunol.180.3.1442.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.3.1442</ArticleId><ArticleId IdType="pubmed">18209039</ArticleId></ArticleIdList></Reference><Reference><Citation>Orban C., Bajnok A., Vasarhelyi B., Tulassay T., Toldi G. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets. Cytom. A. 2014;85:636&#x2013;641. doi: 10.1002/cyto.a.22479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.22479</ArticleId><ArticleId IdType="pubmed">24827427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.D., Srikanth S., Tan Y.V., Yee M.K., Jew M., Damoiseaux R., Jung M.E., Shimizu S., An D.S., Ribalet B., et al. Calcium signaling via Orai1 is essential for induction of the nuclear orphan receptor pathway to drive Th17 differentiation. J. Immunol. 2014;192:110&#x2013;122. doi: 10.4049/jimmunol.1302586.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302586</ArticleId><ArticleId IdType="pmc">PMC3874217</ArticleId><ArticleId IdType="pubmed">24307733</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo J.S., Srikanth S., Kim K.D., Elsaesser H., Lu J., Pellegrini M., Brooks D.G., Sun Z., Gwack Y. CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J. Immunol. 2018;201:1174&#x2013;1185. doi: 10.4049/jimmunol.1800659.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800659</ArticleId><ArticleId IdType="pmc">PMC6081249</ArticleId><ArticleId IdType="pubmed">29987160</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth S., Woo J.S., Sun Z., Gwack Y. Immunological Disorders: Regulation of Ca2+ Signaling in T Lymphocytes. Adv. Exp. Med. Biol. 2017;993:397&#x2013;424. doi: 10.1007/978-3-319-57732-6_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-57732-6_21</ArticleId><ArticleId IdType="pmc">PMC8957800</ArticleId><ArticleId IdType="pubmed">28900926</ArticleId></ArticleIdList></Reference><Reference><Citation>Januzi L., Poirier J.W., Maksoud M.J.E., Xiang Y.Y., Veldhuizen R.A.W., Gill S.E., Cregan S.P., Zhang H., Dekaban G.A., Lu W.Y. Autocrine GABA signaling distinctively regulates phenotypic activation of mouse pulmonary macrophages. Cell. Immunol. 2018;332:7&#x2013;23. doi: 10.1016/j.cellimm.2018.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2018.07.001</ArticleId><ArticleId IdType="pubmed">30017085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler D.W., Thompson A.J., Corletto F., Reckless J., Loke J.C., Lapaque N., Grant A.J., Mastroeni P., Grainger D.J., Padgett C.L., et al. Anaesthetic impairment of immune function is mediated via GABAA receptors. PLoS ONE. 2011;6:e17152. doi: 10.1371/journal.pone.0017152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017152</ArticleId><ArticleId IdType="pmc">PMC3044756</ArticleId><ArticleId IdType="pubmed">21390329</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Garcia M.G., Hernandez-Hernandez F., Hernandez-Tellez B., Garcia-Tamayo F. GABAA receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production. J. Neuroimmunol. 2007;188:64&#x2013;68. doi: 10.1016/j.jneuroim.2007.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.05.013</ArticleId><ArticleId IdType="pubmed">17599468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandage A.K., Friedrich L.M., Kanatani S., Jakobsson-Bjorken S., Escrig-Larena J.I., Wagner A.K., Chambers B.J., Barragan A. GABAergic signaling in human and murine NK cells upon challenge with Toxoplasma gondii. J. Leukoc. Biol. 2021;110:617&#x2013;628. doi: 10.1002/JLB.3HI0720-431R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3HI0720-431R</ArticleId><ArticleId IdType="pubmed">34028876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.K., Kim Y.S., Lee H.M., Jin H.S., Neupane C., Kim S., Lee S.H., Min J.J., Sasai M., Jeong J.H., et al. GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat. Commun. 2018;9:4184. doi: 10.1038/s41467-018-06487-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06487-5</ArticleId><ArticleId IdType="pmc">PMC6180030</ArticleId><ArticleId IdType="pubmed">30305619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandage A.K., Olivera G.C., Kanatani S., Thompson E., Lore K., Varas-Godoy M., Barragan A. A motogenic GABAergic system of mononuclear phagocytes facilitates dissemination of coccidian parasites. Elife. 2020;9:e60528. doi: 10.7554/eLife.60528.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60528</ArticleId><ArticleId IdType="pmc">PMC7685707</ArticleId><ArticleId IdType="pubmed">33179597</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Mao J., Wei B., Pei G. The anti-spasticity drug baclofen alleviates collagen-induced arthritis and regulates dendritic cells. J. Cell. Physiol. 2015;230:1438&#x2013;1447. doi: 10.1002/jcp.24884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24884</ArticleId><ArticleId IdType="pubmed">25556830</ArticleId></ArticleIdList></Reference><Reference><Citation>Duthey B., Hubner A., Diehl S., Boehncke S., Pfeffer J., Boehncke W.H. Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp. Dermatol. 2010;19:661&#x2013;666. doi: 10.1111/j.1600-0625.2010.01076.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0625.2010.01076.x</ArticleId><ArticleId IdType="pubmed">20201957</ArticleId></ArticleIdList></Reference><Reference><Citation>Beales P.E., Hawa M., Williams A.J., Albertini M.C., Giorgini A., Pozzilli P. Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse. Acta Diabetol. 1995;32:53&#x2013;56. doi: 10.1007/BF00581047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00581047</ArticleId><ArticleId IdType="pubmed">7612919</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Middleton B., Lee V.S., Park H.W., Zhang Z., Kim B., Lowe C., Nguyen N., Liu H., Beyer R.S., et al. GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice. Biomedicines. 2021;9:43. doi: 10.3390/biomedicines9010043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9010043</ArticleId><ArticleId IdType="pmc">PMC7825043</ArticleId><ArticleId IdType="pubmed">33418884</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowley T., Fitzpatrick J.M., Kuijper T., Cryan J.F., O&#x2019;Toole O., O&#x2019;Leary O.F., Downer E.J. Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: Relevance to therapeutic effects in multiple sclerosis. Front. Cell. Neurosci. 2015;9:284. doi: 10.3389/fncel.2015.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00284</ArticleId><ArticleId IdType="pmc">PMC4516894</ArticleId><ArticleId IdType="pubmed">26283920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandage A.K., Cunningham J.L., Jin Z., Shen Q., Bongiovanni S., Korol S.V., Syk M., Kamali-Moghaddam M., Ekselius L., Birnir B. Depression, GABA, and Age Correlate with Plasma Levels of Inflammatory Markers. Int. J. Mol. Sci. 2019;20:6172. doi: 10.3390/ijms20246172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246172</ArticleId><ArticleId IdType="pmc">PMC6941074</ArticleId><ArticleId IdType="pubmed">31817800</ArticleId></ArticleIdList></Reference><Reference><Citation>David M., Richer M., Mamarbachi A.M., Villeneuve L.R., Dupre D.J., Hebert T.E. Interactions between GABA-B1 receptors and Kir 3 inwardly rectifying potassium channels. Cell Signal. 2006;18:2172&#x2013;2181. doi: 10.1016/j.cellsig.2006.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2006.05.014</ArticleId><ArticleId IdType="pubmed">16809021</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer M., David M., Villeneuve L.R., Trieu P., Ethier N., Petrin D., Mamarbachi A.M., Hebert T.E. GABA-B1 receptors are coupled to the ERK1/2 MAP kinase pathway in the absence of GABA-B2 subunits. J. Mol. Neurosci. 2009;38:67&#x2013;79. doi: 10.1007/s12031-008-9163-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-008-9163-6</ArticleId><ArticleId IdType="pubmed">19052921</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloucoune G.A., Chun L., Zhang W., Xu C., Huang S., Sun Q., Wang Y., Tu H., Liu J. GABAB receptor subunit GB1 at the cell surface independently activates ERK1/2 through IGF-1R transactivation. PLoS ONE. 2012;7:e39698. doi: 10.1371/journal.pone.0039698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039698</ArticleId><ArticleId IdType="pmc">PMC3386256</ArticleId><ArticleId IdType="pubmed">22761875</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez G.M., Incedal T.C., Prada J., O&#x2019;Callaghan P., Dyachok O., Echeverry S., Dumral O., Nguyen P.M., Xie B., Barg S., et al. The beta-cell primary cilium is an autonomous Ca2+ compartment for paracrine GABA signaling. J. Cell. Biol. 2023;222:e202108101. doi: 10.1083/jcb.202108101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202108101</ArticleId><ArticleId IdType="pmc">PMC9813980</ArticleId><ArticleId IdType="pubmed">36350286</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 1995;182:75&#x2013;85. doi: 10.1084/jem.182.1.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.182.1.75</ArticleId><ArticleId IdType="pmc">PMC2192093</ArticleId><ArticleId IdType="pubmed">7540658</ArticleId></ArticleIdList></Reference><Reference><Citation>Targoni O.S., Baus J., Hofstetter H.H., Hesse M.D., Karulin A.Y., Boehm B.O., Forsthuber T.G., Lehmann P.V. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 2001;166:4757&#x2013;4764. doi: 10.4049/jimmunol.166.7.4757.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.7.4757</ArticleId><ArticleId IdType="pubmed">11254738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuerten S., Rottlaender A., Rodi M., Velasco V.B., Jr., Schroeter M., Kaiser C., Addicks K., Tary-Lehmann M., Lehmann P.V. The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood. Clin. Immunol. 2010;137:422&#x2013;432. doi: 10.1016/j.clim.2010.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2010.09.004</ArticleId><ArticleId IdType="pubmed">20933475</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005;11:335&#x2013;339. doi: 10.1038/nm1202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1202</ArticleId><ArticleId IdType="pubmed">15735651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastain E.M., Duncan D.S., Rodgers J.M., Miller S.D. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta. 2011;1812:265&#x2013;274. doi: 10.1016/j.bbadis.2010.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.07.008</ArticleId><ArticleId IdType="pmc">PMC2970677</ArticleId><ArticleId IdType="pubmed">20637861</ArticleId></ArticleIdList></Reference><Reference><Citation>Almolda B., Gonzalez B., Castellano B. Antigen presentation in EAE: Role of microglia, macrophages and dendritic cells. Front. Biosci. 2011;16:1157&#x2013;1171. doi: 10.2741/3781.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3781</ArticleId><ArticleId IdType="pubmed">21196224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn S.A., van Landeghem F.K., Zacharias R., Farber K., Rappert A., Pavlovic S., Hoffmann A., Nolte C., Kettenmann H. Microglia express GABAB receptors to modulate interleukin release. Mol. Cell. Neurosci. 2004;25:312&#x2013;322. doi: 10.1016/j.mcn.2003.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2003.10.023</ArticleId><ArticleId IdType="pubmed">15019947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead E.L., Mosley A., Eaton S., Dobson L., Heales S.J., Pocock J.M. Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J. Neurochem. 2012;121:287&#x2013;301. doi: 10.1111/j.1471-4159.2012.07659.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07659.x</ArticleId><ArticleId IdType="pubmed">22243365</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Schwab C., McGeer P.L. Astrocytes are GABAergic cells that modulate microglial activity. Glia. 2011;59:152&#x2013;165. doi: 10.1002/glia.21087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21087</ArticleId><ArticleId IdType="pubmed">21046567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., McGeer E.G., McGeer P.L. Mechanisms of GABA release from human astrocytes. Pt AGlia. 2011;59:1600&#x2013;1611. doi: 10.1002/glia.21202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21202</ArticleId><ArticleId IdType="pubmed">21748804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolini C., Fahnestock M. The valproic acid-induced rodent model of autism. Exp. Neurol. 2018;299:217&#x2013;227. doi: 10.1016/j.expneurol.2017.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.04.017</ArticleId><ArticleId IdType="pubmed">28472621</ArticleId></ArticleIdList></Reference><Reference><Citation>Singla R., Mishra A., Joshi R., Sarma P., Kumar R., Kaur G., Sharma A.R., Jain A., Prakash A., Bhatia A., et al. Homotaurine ameliorates the core ASD symptomatology in VPA rats through GABAergic signaling: Role of GAD67. Brain Res. Bull. 2022;190:122&#x2013;133. doi: 10.1016/j.brainresbull.2022.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2022.09.003</ArticleId><ArticleId IdType="pubmed">36113682</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano S., Aguera L., Aguilar M., Olazaran J. A Review on Tramiprosate (Homotaurine) in Alzheimer&#x2019;s Disease and Other Neurocognitive Disorders. Front. Neurol. 2020;11:614. doi: 10.3389/fneur.2020.00614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00614</ArticleId><ArticleId IdType="pmc">PMC7358344</ArticleId><ArticleId IdType="pubmed">32733362</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen P.S., Gauthier S., Ferris S.H., Saumier D., Haine D., Garceau D., Duong A., Suhy J., Oh J., Lau W.C., et al. Tramiprosate in mild-to-moderate Alzheimer&#x2019;s disease&#x2014;A randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study) Arch. Med. Sci. 2010;7:102&#x2013;111. doi: 10.5114/aoms.2011.20612.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2011.20612</ArticleId><ArticleId IdType="pmc">PMC3258678</ArticleId><ArticleId IdType="pubmed">22291741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsolaki M. Future strategies of management of Alzheimer&#x2019;s Disease. The role of homotaurine. Hell. J. Nucl. Med. 2019;22:82&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">30877726</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier S., Aisen P.S., Ferris S.H., Saumier D., Duong A., Haine D., Garceau D., Suhy J., Oh J., Lau W., et al. Effect of tramiprosate in patients with mild-to-moderate Alzheimer&#x2019;s disease: Exploratory analyses of the MRI sub-group of the Alphase study. J. Nutr. Health Aging. 2009;13:550&#x2013;557. doi: 10.1007/s12603-009-0106-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-009-0106-x</ArticleId><ArticleId IdType="pubmed">19536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Toppi E., Sireno L., Lembo M., Banaj N., Messina B., Golesorkhtafti S., Spalletta G., Bossu P. IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment. Front. Immunol. 2022;13:813951. doi: 10.3389/fimmu.2022.813951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.813951</ArticleId><ArticleId IdType="pmc">PMC9061963</ArticleId><ArticleId IdType="pubmed">35515001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Liu L., Wang T., Cannon M., Lin P., Fan T.W., Scott D.A., Wu H.J., Lane A.N., Wang R. GAB functions as a bioenergetic and signalling gatekeeper to control T cell inflammation. Nat. Metab. 2022;4:1322&#x2013;1335. doi: 10.1038/s42255-022-00638-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00638-1</ArticleId><ArticleId IdType="pmc">PMC9584824</ArticleId><ArticleId IdType="pubmed">36192601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandage A.K., Jin Z., Korol S.V., Shen Q., Pei Y., Deng Q., Espes D., Carlsson P.O., Kamali-Moghaddam M., Birnir B. GABA Regulates Release of Inflammatory Cytokines From Peripheral Blood Mononuclear Cells and CD4+ T Cells and Is Immunosuppressive in Type 1 Diabetes. EBioMedicine. 2018;30:283&#x2013;294. doi: 10.1016/j.ebiom.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.03.019</ArticleId><ArticleId IdType="pmc">PMC5952354</ArticleId><ArticleId IdType="pubmed">29627388</ArticleId></ArticleIdList></Reference><Reference><Citation>Semyanov A., Walker M.C., Kullmann D.M., Silver R.A. Tonically active GABA A receptors: Modulating gain and maintaining the tone. Trends Neurosci. 2004;27:262&#x2013;269. doi: 10.1016/j.tins.2004.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2004.03.005</ArticleId><ArticleId IdType="pubmed">15111008</ArticleId></ArticleIdList></Reference><Reference><Citation>Glykys J., Mody I. Activation of GABAA receptors: Views from outside the synaptic cleft. Neuron. 2007;56:763&#x2013;770. doi: 10.1016/j.neuron.2007.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.11.002</ArticleId><ArticleId IdType="pubmed">18054854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mody I., De Koninck Y., Otis T.S., Soltesz I. Bridging the cleft at GABA synapses in the brain. Trends Neurosci. 1994;17:517&#x2013;525. doi: 10.1016/0166-2236(94)90155-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(94)90155-4</ArticleId><ArticleId IdType="pubmed">7532336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon B.E., Woo J., Chun Y.E., Chun H., Jo S., Bae J.Y., An H., Min J.O., Oh S.J., Han K.S., et al. Glial GABA, synthesized by monoamine oxidase B, mediates tonic inhibition. J. Physiol. 2014;592:4951&#x2013;4968. doi: 10.1113/jphysiol.2014.278754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2014.278754</ArticleId><ArticleId IdType="pmc">PMC4259537</ArticleId><ArticleId IdType="pubmed">25239459</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnir B., Korpi E.R. The impact of sub-cellular location and intracellular neuronal proteins on properties of GABA(A) receptors. Curr. Pharm. Des. 2007;13:3169&#x2013;3177. doi: 10.2174/138161207782341330.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161207782341330</ArticleId><ArticleId IdType="pubmed">18045166</ArticleId></ArticleIdList></Reference><Reference><Citation>Brickley S.G., Cull-Candy S.G., Farrant M. Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. Pt 3J. Physiol. 1996;497:753&#x2013;759. doi: 10.1113/jphysiol.1996.sp021806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1996.sp021806</ArticleId><ArticleId IdType="pmc">PMC1160971</ArticleId><ArticleId IdType="pubmed">9003560</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall M.J., Usowicz M.M. Development of action potential-dependent and independent spontaneous GABAA receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur. J. Neurosci. 1997;9:533&#x2013;548. doi: 10.1111/j.1460-9568.1997.tb01630.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1997.tb01630.x</ArticleId><ArticleId IdType="pubmed">9104595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusser Z., Sieghart W., Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 1998;18:1693&#x2013;1703. doi: 10.1523/JNEUROSCI.18-05-01693.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-05-01693.1998</ArticleId><ArticleId IdType="pmc">PMC6792611</ArticleId><ArticleId IdType="pubmed">9464994</ArticleId></ArticleIdList></Reference><Reference><Citation>Richerson G.B. Looking for GABA in all the wrong places: The relevance of extrasynaptic GABAA receptors to epilepsy. Epilepsy Curr. 2004;4:239&#x2013;242. doi: 10.1111/j.1535-7597.2004.46008.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1535-7597.2004.46008.x</ArticleId><ArticleId IdType="pmc">PMC1176385</ArticleId><ArticleId IdType="pubmed">16059513</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrant M., Kaila K. The cellular, molecular and ionic basis of GABAA receptor signalling. Prog. Brain Res. 2007;160:59&#x2013;87. doi: 10.1016/S0079-6123(06)60005-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6123(06)60005-8</ArticleId><ArticleId IdType="pubmed">17499109</ArticleId></ArticleIdList></Reference><Reference><Citation>Storustovu S.I., Ebert B. Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J. Pharmacol. Exp. Ther. 2006;316:1351&#x2013;1359. doi: 10.1124/jpet.105.092403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.105.092403</ArticleId><ArticleId IdType="pubmed">16272218</ArticleId></ArticleIdList></Reference><Reference><Citation>Meera P., Wallner M., Otis T.S. Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABAA receptors. J. Neurophysiol. 2011;106:2057&#x2013;2064. doi: 10.1152/jn.00450.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00450.2011</ArticleId><ArticleId IdType="pmc">PMC3191842</ArticleId><ArticleId IdType="pubmed">21795619</ArticleId></ArticleIdList></Reference><Reference><Citation>Korol S.V., Jin Z., Jin Y., Bhandage A.K., Tengholm A., Gandasi N.R., Barg S., Espes D., Carlsson P.O., Laver D., et al. Functional Characterization of Native, High-Affinity GABA(A) Receptors in Human Pancreatic beta Cells. EBioMedicine. 2018;30:273&#x2013;282. doi: 10.1016/j.ebiom.2018.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.03.014</ArticleId><ArticleId IdType="pmc">PMC5952339</ArticleId><ArticleId IdType="pubmed">29606630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandage A.K., Hellgren C., Jin Z., Olafsson E.B., Sundstrom-Poromaa I., Birnir B. Expression of GABA receptors subunits in peripheral blood mononuclear cells is gender dependent, altered in pregnancy and modified by mental health. Acta Physiol. 2015;213:575&#x2013;585. doi: 10.1111/apha.12440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12440</ArticleId><ArticleId IdType="pubmed">25529063</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D., Wang Y., Thompson J.W., Yin T., Alexander P.B., Qin D., Mudgal P., Wu H., Liang Y., Tan L., et al. Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression. Nat. Cell. Biol. 2022;24:230&#x2013;241. doi: 10.1038/s41556-021-00820-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-021-00820-9</ArticleId><ArticleId IdType="pmc">PMC8852304</ArticleId><ArticleId IdType="pubmed">35145222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman D.L. GABA molecules made by B cells can dampen antitumour responses. Nature. 2021;599:374&#x2013;376. doi: 10.1038/d41586-021-02953-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-02953-1</ArticleId><ArticleId IdType="pubmed">34732882</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D., Alexander P.B., Li Q.J., Wang X.F. GABAergic signaling beyond synapses: An emerging target for cancer therapy. Trends Cell. Biol. 2022 doi: 10.1016/j.tcb.2022.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2022.08.004</ArticleId><ArticleId IdType="pmc">PMC10008753</ArticleId><ArticleId IdType="pubmed">36114091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.B., Myung S.K., Park Y.C., Park B. Use of benzodiazepine and risk of cancer: A meta-analysis of observational studies. Int. J. Cancer. 2017;140:513&#x2013;525. doi: 10.1002/ijc.30443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.30443</ArticleId><ArticleId IdType="pubmed">27667780</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinerman R.A., Brinton L.A., Hoover R., Fraumeni J.F., Jr. Diazepam use and progression of breast cancer. Cancer Res. 1984;44:1223&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">6692406</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonsack F., Sukumari-Ramesh S. TSPO: An Evolutionarily Conserved Protein with Elusive Functions. Int. J. Mol. Sci. 2018;19:1694. doi: 10.3390/ijms19061694.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19061694</ArticleId><ArticleId IdType="pmc">PMC6032217</ArticleId><ArticleId IdType="pubmed">29875327</ArticleId></ArticleIdList></Reference><Reference><Citation>Jow F., Chiu D., Lim H.K., Novak T., Lin S. Production of GABA by cultured hippocampal glial cells. Neurochem. Int. 2004;45:273&#x2013;283. doi: 10.1016/j.neuint.2003.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2003.11.021</ArticleId><ArticleId IdType="pubmed">15145543</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q.Y., Schaffner A.E., Chang Y.H., Maric D., Barker J.L. Persistent activation of GABAA receptor/Cl&#x2212; channels by astrocyte-derived GABA in cultured embryonic rat hippocampal neurons. J. Neurophysiol. 2000;84:1392&#x2013;1403. doi: 10.1152/jn.2000.84.3.1392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2000.84.3.1392</ArticleId><ArticleId IdType="pubmed">10980012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov A.S., Angulo M.C., Audinat E., Charpak S. Target cell-specific modulation of neuronal activity by astrocytes. Proc. Natl. Acad. Sci. USA. 2006;103:10058&#x2013;10063. doi: 10.1073/pnas.0603741103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603741103</ArticleId><ArticleId IdType="pmc">PMC1502505</ArticleId><ArticleId IdType="pubmed">16782808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Gonzalez C., Pirttimaki T., Cope D.W., Parri H.R. Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets delta-subunit-containing GABAA receptors. Eur. J. Neurosci. 2011;33:1471&#x2013;1482. doi: 10.1111/j.1460-9568.2011.07645.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2011.07645.x</ArticleId><ArticleId IdType="pmc">PMC3110310</ArticleId><ArticleId IdType="pubmed">21395866</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Meur K., Mendizabal-Zubiaga J., Grandes P., Audinat E. GABA release by hippocampal astrocytes. Front. Comput. Neurosci. 2012;6:59. doi: 10.3389/fncom.2012.00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncom.2012.00059</ArticleId><ArticleId IdType="pmc">PMC3421239</ArticleId><ArticleId IdType="pubmed">22912614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.M., Chang Y.Y., Kuo J.S., Sun S.H. Activation of P2X7 receptors induced [3H]GABA release from the RBA-2 type-2 astrocyte cell line through a Cl&#x2212;/HCO3&#x2212;-dependent mechanism. Glia. 2002;37:8&#x2013;18. doi: 10.1002/glia.10004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10004</ArticleId><ArticleId IdType="pubmed">11746779</ArticleId></ArticleIdList></Reference><Reference><Citation>Doblas S., He T., Saunders D., Hoyle J., Smith N., Pye Q., Lerner M., Jensen R.L., Towner R.A. In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed. 2012;25:685&#x2013;694. doi: 10.1002/nbm.1785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1785</ArticleId><ArticleId IdType="pmc">PMC3780579</ArticleId><ArticleId IdType="pubmed">21954105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Wang R., Ferris B., Salit J., Strulovici-Barel Y., Hackett N.R., Crystal R.G. Smoking-mediated up-regulation of GAD67 expression in the human airway epithelium. Respir. Res. 2010;11:150. doi: 10.1186/1465-9921-11-150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-11-150</ArticleId><ArticleId IdType="pmc">PMC2988726</ArticleId><ArticleId IdType="pubmed">21034448</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabumoto Y., Watanabe M., Ito Y., Maemura K., Otsuki Y., Nakamura Y., Yanagawa Y., Obata K., Watanabe K. Expression of GABAergic system in pulmonary neuroendocrine cells and airway epithelial cells in GAD67-GFP knock-in mice. Med. Mol. Morphol. 2008;41:20&#x2013;27. doi: 10.1007/s00795-007-0391-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00795-007-0391-6</ArticleId><ArticleId IdType="pubmed">18470677</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S., Merchant M.L., Ritzenthaler J.D., McLeish K.R., Lederer E.D., Torres-Gonzalez E., Fraig M., Barati M.T., Lentsch A.B., Roman J., et al. Baclofen, a GABABR agonist, ameliorates immune-complex mediated acute lung injury by modulating pro-inflammatory mediators. PLoS ONE. 2015;10:e0121637. doi: 10.1371/journal.pone.0121637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121637</ArticleId><ArticleId IdType="pmc">PMC4388838</ArticleId><ArticleId IdType="pubmed">25848767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Xiang Y.Y., Ellis R., Wattie J., Feng M., Inman M.D., Lu W.Y. Effects of furosemide on allergic asthmatic responses in mice. Clin. Exp. Allergy. 2011;41:1456&#x2013;1467. doi: 10.1111/j.1365-2222.2011.03811.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2011.03811.x</ArticleId><ArticleId IdType="pubmed">21729180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin N., Kolliputi N., Gou D., Weng T., Liu L. A novel function of ionotropic gamma-aminobutyric acid receptors involving alveolar fluid homeostasis. J. Biol. Chem. 2006;281:36012&#x2013;36020. doi: 10.1074/jbc.M606895200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M606895200</ArticleId><ArticleId IdType="pubmed">17003036</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang T., Zhang Y., Wang C., Gao J. Propofol reduces acute lung injury by up-regulating gamma-aminobutyric acid type a receptors. Exp. Mol. Pathol. 2019;110:104295. doi: 10.1016/j.yexmp.2019.104295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2019.104295</ArticleId><ArticleId IdType="pubmed">31419406</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortis S., Spieth P.M., Lu W.Y., Parotto M., Haitsma J.J., Slutsky A.S., Zhong N., Mazer C.D., Zhang H. Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury. Intensive Care Med. 2012;38:1548&#x2013;1555. doi: 10.1007/s00134-012-2610-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2610-4</ArticleId><ArticleId IdType="pmc">PMC4896809</ArticleId><ArticleId IdType="pubmed">22711173</ArticleId></ArticleIdList></Reference><Reference><Citation>Chintagari N.R., Liu L. GABA receptor ameliorates ventilator-induced lung injury in rats by improving alveolar fluid clearance. Crit. Care. 2012;16:R55. doi: 10.1186/cc11298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11298</ArticleId><ArticleId IdType="pmc">PMC3681384</ArticleId><ArticleId IdType="pubmed">22480160</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigtsberger S., Lachmann R.A., Leutert A.C., Schlapfer M., Booy C., Reyes L., Urner M., Schild J., Schimmer R.C., Beck-Schimmer B. Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. Anesthesiology. 2009;111:1238&#x2013;1248. doi: 10.1097/ALN.0b013e3181bdf857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181bdf857</ArticleId><ArticleId IdType="pubmed">19934867</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller S., Strosing K.M., Ryter S.W., Buerkle H., Loop T., Schmidt R., Hoetzel A. The volatile anesthetic isoflurane prevents ventilator-induced lung injury via phosphoinositide 3-kinase/Akt signaling in mice. Anesth. Analg. 2012;114:747&#x2013;756. doi: 10.1213/ANE.0b013e31824762f0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31824762f0</ArticleId><ArticleId IdType="pubmed">22383671</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T., Yamamoto K., Ohmoto N., Ohta K., Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit. Care Med. 2000;28:1101&#x2013;1106. doi: 10.1097/00003246-200004000-00032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200004000-00032</ArticleId><ArticleId IdType="pubmed">10809290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X., Ju Y.N., Gao W., Li D.M., Guo C.C. Desflurane Attenuates Ventilator-Induced Lung Injury in Rats with Acute Respiratory Distress Syndrome. Biomed. Res. Int. 2018;2018:7507314. doi: 10.1155/2018/7507314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7507314</ArticleId><ArticleId IdType="pmc">PMC5833253</ArticleId><ArticleId IdType="pubmed">29670906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud K., Ammar A. Immunomodulatory Effects of Anesthetics during Thoracic Surgery. Anesthesiol. Res. Pract. 2011;2011:317410. doi: 10.1155/2011/317410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/317410</ArticleId><ArticleId IdType="pmc">PMC3205595</ArticleId><ArticleId IdType="pubmed">22110498</ArticleId></ArticleIdList></Reference><Reference><Citation>De Conno E., Steurer M.P., Wittlinger M., Zalunardo M.P., Weder W., Schneiter D., Schimmer R.C., Klaghofer R., Neff T.A., Schmid E.R., et al. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology. 2009;110:1316&#x2013;1326. doi: 10.1097/ALN.0b013e3181a10731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181a10731</ArticleId><ArticleId IdType="pubmed">19417610</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling T., Kozian A., Kretzschmar M., Huth C., Welte T., Buhling F., Hedenstierna G., Hachenberg T. Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br. J. Anaesth. 2007;99:368&#x2013;375. doi: 10.1093/bja/aem184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aem184</ArticleId><ArticleId IdType="pubmed">17621602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochiyama T., Li X., Nakayama H., Kage M., Yamane Y., Takamori K., Iwabuchi K., Inada E. Effect of Propofol on the Production of Inflammatory Cytokines by Human Polarized Macrophages. Mediat. Inflamm. 2019;2019:1919538. doi: 10.1155/2019/1919538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1919538</ArticleId><ArticleId IdType="pmc">PMC6441544</ArticleId><ArticleId IdType="pubmed">31007601</ArticleId></ArticleIdList></Reference><Reference><Citation>Forkuo G.S., Nieman A.N., Kodali R., Zahn N.M., Li G., Rashid Roni M.S., Stephen M.R., Harris T.W., Jahan R., Guthrie M.L., et al. A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung. Mol. Pharm. 2018;15:1766&#x2013;1777. doi: 10.1021/acs.molpharmaceut.7b01013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.7b01013</ArticleId><ArticleId IdType="pmc">PMC5954213</ArticleId><ArticleId IdType="pubmed">29578347</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y.Y., Chen X., Li J., Wang S., Faclier G., Macdonald J.F., Hogg J.C., Orser B.A., Lu W.Y. Isoflurane regulates atypical type-A gamma-aminobutyric acid receptors in alveolar type II epithelial cells. Anesthesiology. 2013;118:1065&#x2013;1075. doi: 10.1097/ALN.0b013e31828e180e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31828e180e</ArticleId><ArticleId IdType="pubmed">23485993</ArticleId></ArticleIdList></Reference><Reference><Citation>Boost K.A., Leipold T., Scheiermann P., Hoegl S., Sadik C.D., Hofstetter C., Zwissler B. Sevoflurane and isoflurane decrease TNF-alpha-induced gene expression in human monocytic THP-1 cells: Potential role of intracellular IkappaBalpha regulation. Int. J. Mol. Med. 2009;23:665&#x2013;671. doi: 10.3892/ijmm_00000178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm_00000178</ArticleId><ArticleId IdType="pubmed">19360326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.S., Lin W.C., Yeh H.T., Hu C.L., Sheu S.M. Propofol specifically reduces PMA-induced neutrophil extracellular trap formation through inhibition of p-ERK and HOCl. Life Sci. 2019;221:178&#x2013;186. doi: 10.1016/j.lfs.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.02.030</ArticleId><ArticleId IdType="pubmed">30771312</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredthauer A., Geiger A., Gruber M., Pfaehler S.M., Petermichl W., Bitzinger D., Metterlein T., Seyfried T. Propofol Ameliorates Exaggerated Human Neutrophil Activation in a LPS Sepsis Model. J. Inflamm. Res. 2021;14:3849&#x2013;3862. doi: 10.2147/JIR.S314192.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S314192</ArticleId><ArticleId IdType="pmc">PMC8366786</ArticleId><ArticleId IdType="pubmed">34408467</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier A., Chien J., Hobohm L., Patras K.A., Nizet V., Corriden R. Inhibition of Human Neutrophil Extracellular Trap (NET) Production by Propofol and Lipid Emulsion. Front. Pharmacol. 2019;10:323. doi: 10.3389/fphar.2019.00323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00323</ArticleId><ArticleId IdType="pmc">PMC6460395</ArticleId><ArticleId IdType="pubmed">31024300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K.H., Lu W.J., Wang S.H., Fong T.H., Chou D.S., Chang C.C., Chang N.C., Chiang Y.C., Huang S.Y., Sheu J.R. Characteristics of endogenous gamma-aminobutyric acid (GABA) in human platelets: Functional studies of a novel collagen glycoprotein VI inhibitor. J. Mol. Med. 2014;92:603&#x2013;614. doi: 10.1007/s00109-014-1140-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-014-1140-7</ArticleId><ArticleId IdType="pubmed">24626935</ArticleId></ArticleIdList></Reference><Reference><Citation>De Albuquerque N., Baig E., Ma X., Zhang J., He W., Rowe A., Habal M., Liu M., Shalev I., Downey G.P., et al. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J. Virol. 2006;80:10382&#x2013;10394. doi: 10.1128/JVI.00747-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00747-06</ArticleId><ArticleId IdType="pmc">PMC1641767</ArticleId><ArticleId IdType="pubmed">17041219</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar A., Hartwig S.M., Haag B.A., Meyerholz D.K., Epping L.L., Haring J.S., Varga S.M., Harty J.T. Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: Implications for severe acute respiratory syndrome. J. Virol. 2009;83:9258&#x2013;9272. doi: 10.1128/JVI.00355-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00355-09</ArticleId><ArticleId IdType="pmc">PMC2738266</ArticleId><ArticleId IdType="pubmed">19570864</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar A., Hartwig S.M., Haag B.A., Meyerholz D.K., Harty J.T., Varga S.M. Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice. J. Virol. 2009;83:8946&#x2013;8956. doi: 10.1128/JVI.01857-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01857-08</ArticleId><ArticleId IdType="pmc">PMC2738158</ArticleId><ArticleId IdType="pubmed">19553337</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar A., Fulton R.B., Epping L.L., Pham N.L., Tifrea D., Varga S.M., Harty J.T. T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts. J. Immunol. 2010;185:1132&#x2013;1141. doi: 10.4049/jimmunol.0902749.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902749</ArticleId><ArticleId IdType="pmc">PMC2897948</ArticleId><ArticleId IdType="pubmed">20554960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Middleton B., Kaufman D.L. GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice. Viruses. 2021;13:966. doi: 10.3390/v13060966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13060966</ArticleId><ArticleId IdType="pmc">PMC8224554</ArticleId><ArticleId IdType="pubmed">34071034</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner R.W., Majjouti M., Alcazar M.A.A., Mahabir E. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2. Viruses. 2020;12:880. doi: 10.3390/v12080880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12080880</ArticleId><ArticleId IdType="pmc">PMC7471983</ArticleId><ArticleId IdType="pubmed">32806708</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P.B., Jr., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D., et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 2007;81:813&#x2013;821. doi: 10.1128/JVI.02012-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau G.B., Burgess S.L., Sturek J.M., Donlan A.N., Petri W.A., Mann B.J. Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection. Am. J. Trop. Med. Hyg. 2020;103:1215&#x2013;1219. doi: 10.4269/ajtmh.20-0762.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0762</ArticleId><ArticleId IdType="pmc">PMC7470527</ArticleId><ArticleId IdType="pubmed">32723427</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathnasinghe R., Strohmeier S., Amanat F., Gillespie V.L., Krammer F., Garcia-Sastre A., Coughlan L., Schotsaert M., Uccellini M.B. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg. Microbes Infect. 2020;9:2433&#x2013;2445. doi: 10.1080/22221751.2020.1838955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1838955</ArticleId><ArticleId IdType="pmc">PMC7655046</ArticleId><ArticleId IdType="pubmed">33073694</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden J.W., Cline C.R., Zeng X., Garrison A.R., Carey B.D., Mucker E.M., White L.E., Shamblin J.D., Brocato R.L., Liu J., et al. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight. 2020;5:e142032. doi: 10.1172/jci.insight.142032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.142032</ArticleId><ArticleId IdType="pmc">PMC7566707</ArticleId><ArticleId IdType="pubmed">32841215</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.S., Bailey A.L., Kafai N.M., Nair S., McCune B.T., Yu J., Fox J.M., Chen R.E., Earnest J.T., Keeler S.P., et al. SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function. bioRxiv. 2020 doi: 10.1101/2020.07.09.196188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.09.196188</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladunni F.S., Park J.G., Pino P.A., Gonzalez O., Akhter A., Allue-Guardia A., Olmo-Fontanez A., Gautam S., Garcia-Vilanova A., Ye C., et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 2020;11:6122. doi: 10.1038/s41467-020-19891-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19891-7</ArticleId><ArticleId IdType="pmc">PMC7705712</ArticleId><ArticleId IdType="pubmed">33257679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Dillion B.J., Henley J., Comai L., Kaufman D.L. A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice. Front. Immunol. 2022;13:1007955. doi: 10.3389/fimmu.2022.1007955.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1007955</ArticleId><ArticleId IdType="pmc">PMC9640739</ArticleId><ArticleId IdType="pubmed">36389819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal P., Wang S., Liu S., Xiang Y.Y., Lu W.Y., Wang Q. GABA coordinates with insulin in regulating secretory function in pancreatic INS-1 beta-cells. PLoS ONE. 2011;6:e26225. doi: 10.1371/journal.pone.0026225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026225</ArticleId><ArticleId IdType="pmc">PMC3198728</ArticleId><ArticleId IdType="pubmed">22031825</ArticleId></ArticleIdList></Reference><Reference><Citation>Rorsman P., Berggren P.O., Bokvist K., Ericson H., Mohler H., Ostenson C.G., Smith P.A. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature. 1989;341:233&#x2013;236. doi: 10.1038/341233a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/341233a0</ArticleId><ArticleId IdType="pubmed">2550826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai D., Fang L., Xia S., Ke W., Wang J., Wu X., Fang P., Xiao S. Porcine deltacoronavirus (PDCoV) modulates calcium influx to favor viral replication. Virology. 2020;539:38&#x2013;48. doi: 10.1016/j.virol.2019.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2019.10.011</ArticleId><ArticleId IdType="pmc">PMC7112098</ArticleId><ArticleId IdType="pubmed">31670218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraeft S.K., Chen D.S., Li H.P., Chen L.B., Lai M.M. Mouse hepatitis virus infection induces an early, transient calcium influx in mouse astrocytoma cells. Exp. Cell. Res. 1997;237:55&#x2013;62. doi: 10.1006/excr.1997.3768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1997.3768</ArticleId><ArticleId IdType="pmc">PMC7133765</ArticleId><ArticleId IdType="pubmed">9417866</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., et al. SARS-CoV-2 infection results in lasting and systemic perturbations post recovery. bioRxiv. 2022 doi: 10.1101/2022.01.18.476786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.18.476786</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari C.C., Veras F.P., Vendramini P.H., Valen&#xe7;a A.G.F., Antunes A.S.L.M. Morphological, cellular and molecular basis of brain infection in COVID-19 patients. MedRxiv. 2020;16 doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Virhammar J., Naas A., Fallmar D., Cunningham J.L., Klang A., Ashton N.J., Jackmann S., Westman G., Frithiof R., Blennow K., et al. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Eur. J. Neurol. 2021;28:3324&#x2013;3331. doi: 10.1111/ene.14703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14703</ArticleId><ArticleId IdType="pmc">PMC8518988</ArticleId><ArticleId IdType="pubmed">33369818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.M., Yilmaz A., Lindh M., Nilsson S., Price R.W., Blennow K., Zetterberg H., Gisslen M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;e1759. doi: 10.1212/WNL.0000000000010111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010111</ArticleId><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. Microvascular Injury in the Brains of Patients with COVID-19. N. Engl. J. Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A., Mohamed M.S., Moulin T.C., Schioth H.B. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J. Neuroimmunol. 2021;358:577658. doi: 10.1016/j.jneuroim.2021.577658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577658</ArticleId><ArticleId IdType="pmc">PMC8272134</ArticleId><ArticleId IdType="pubmed">34304141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Dang H., Kaufman D.L. Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ss-cells in diabetic NOD mice. PLoS ONE. 2011;6:e25337. doi: 10.1371/journal.pone.0025337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025337</ArticleId><ArticleId IdType="pmc">PMC3178649</ArticleId><ArticleId IdType="pubmed">21966502</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Lau H.K., Son D.O., Jin T., Yang Y., Zhang Z., Li Y., Prud&#x2019;homme G.J., Wang Q. Combined use of GABA and sitagliptin promotes human beta-cell proliferation and reduces apoptosis. J. Endocrinol. 2021;248:133&#x2013;143. doi: 10.1530/JOE-20-0315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-20-0315</ArticleId><ArticleId IdType="pubmed">33258801</ArticleId></ArticleIdList></Reference><Reference><Citation>Son D.O., Liu W., Li X., Prud&#x2019;homme G.J., Wang Q. Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic beta-cell line and isolated human islets. J. Diabetes. 2019;11:563&#x2013;572. doi: 10.1111/1753-0407.12881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.12881</ArticleId><ArticleId IdType="pubmed">30520247</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Glinka Y., Kurt M., Liu W., Wang Q. The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells. Biochem. Biophys. Res. Commun. 2017;493:1542&#x2013;1547. doi: 10.1016/j.bbrc.2017.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.10.029</ArticleId><ArticleId IdType="pubmed">28993191</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Song M., Kaufman D.L. Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases-The Case for Using Ignored Target Cell Antigen Determinants. Cells. 2022;11:1081. doi: 10.3390/cells11071081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071081</ArticleId><ArticleId IdType="pmc">PMC8997884</ArticleId><ArticleId IdType="pubmed">35406645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Ren L., Wan Y., Prud&#x2019;homme G.J. GABAergic regulation of pancreatic islet cells: Physiology and antidiabetic effects. J. Cell. Physiol. 2019;234:14432&#x2013;14444. doi: 10.1002/jcp.28214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28214</ArticleId><ArticleId IdType="pubmed">30693506</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>